GSH Response


GSH response copolymers have gained significant attention in the field of drug delivery due to their ability to selectively release drugs in GSH-rich environments, such as tumor cells. This targeted drug delivery approach holds the potential to enhance the therapeutic efficacy of anticancer drugs while minimizing their systemic toxicity. When the GSH response copolymer reaches the target tissue or cell, which is often characterized by higher GSH levels compared to healthy tissue, the presence of GSH triggers the cleavage or disassembly of the copolymer structure. This cleavage event can lead to the release of the encapsulated drug or detachment of the drug from the copolymer backbone, thereby achieving site-specific drug delivery.

PLGA-SS-PEG-FITC/RB/CY/ICG

Catalog: PHRC72

MW: N/A

PLGA-SS-PEG-Folate

Catalog: PHRC123

MW: N/A

PLGA-SS-PEG-Hyd

Catalog: PHRC61

MW: N/A

PLGA-SS-PEG-MAL

Catalog: PHRC65

MW: N/A

PLGA-SS-PEG-N3

Catalog: PHRC69

MW: N/A

PLGA-SS-PEG-NH2

Catalog: PHRC64

MW: N/A

PLGA-SS-PEG-NHS

Catalog: PHRC66

MW: N/A

PLGA-SS-PEG-OH

Catalog: PHRC121

MW: N/A

PLGA-SS-PEG-PLGA

Catalog: PHRC76

MW: N/A

PLGA-SS-PEG-PTX

Catalog: PHRC127

MW: N/A

PLGA-SS-PEG-RB

Catalog: PHRC118

MW: N/A

PLGA-SS-PEG-SH

Catalog: PHRC68

MW: N/A

PLGA-SS-PEI

Catalog: PHRC278

MW: N/A

PLLA-SS-PEI

Catalog: PHRC277

MW: N/A

RGD-PEG-SS-PEI

Catalog: PHRC54

MW: N/A

Products
Fill out the form below
to receive a quote

GET A QUOTE

  • (USA)
  • (Europe)
Cookie Policy | Privacy Policy | Copyright © 2024 CD Bioparticles. All rights reserved.
0
Inquiry Basket
Inquiry